CDKN2B is critical for verapamil-mediated reversal of doxorubicin resistance in hepatocellular carcinoma

In this study, we explored the function and mechanism of CDKN2B genes in verapamil (VER)-induced reversal of resistance to doxorubicin (ADM) chemotherapy in hepatocellular carcinoma (HCC). We examined 4 HCC cell lines and found that the expression levels of CDKN2B genes correlated with the level of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tengyue, Ma, Kelong, Huang, Jin, Wang, Shitang, Liu, Yabei, Fan, Gaofei, Liu, Miao, Yang, Guangshan, Wang, Cheng, Fan, Pingsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746364/
https://www.ncbi.nlm.nih.gov/pubmed/29299129
http://dx.doi.org/10.18632/oncotarget.22123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746364/
https://www.ncbi.nlm.nih.gov/pubmed/29299129
http://dx.doi.org/10.18632/oncotarget.22123

Ejemplares similares